338 related articles for article (PubMed ID: 21730304)
1. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.
Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S
Circulation; 2011 Jul; 124(4):454-64. PubMed ID: 21730304
[TBL] [Abstract][Full Text] [Related]
2. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
6. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.
Hu L; Boesten LS; May P; Herz J; Bovenschen N; Huisman MV; Berbée JF; Havekes LM; van Vlijmen BJ; Tamsma JT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2710-5. PubMed ID: 17038633
[TBL] [Abstract][Full Text] [Related]
7. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
[TBL] [Abstract][Full Text] [Related]
9. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
Parks BW; Srivastava R; Yu S; Kabarowski JH
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.
Brophy ML; Dong Y; Tao H; Yancey PG; Song K; Zhang K; Wen A; Wu H; Lee Y; Malovichko MV; Sithu SD; Wong S; Yu L; Kocher O; Bischoff J; Srivastava S; Linton MF; Ley K; Chen H
Circ Res; 2019 Feb; 124(4):e6-e19. PubMed ID: 30595089
[TBL] [Abstract][Full Text] [Related]
11. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
12. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.
Yancey PG; Blakemore J; Ding L; Fan D; Overton CD; Zhang Y; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):787-95. PubMed ID: 20150557
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.
Brown AL; Zhu X; Rong S; Shewale S; Seo J; Boudyguina E; Gebre AK; Alexander-Miller MA; Parks JS
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2122-30. PubMed ID: 22814747
[TBL] [Abstract][Full Text] [Related]
15. Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile.
Eberlé D; Luk FS; Kim RY; Olivas VR; Kumar N; Posada JM; Li K; Gaudreault N; Rapp JH; Raffai RL
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1759-67. PubMed ID: 23788760
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis.
Gordts PL; Reekmans S; Lauwers A; Van Dongen A; Verbeek L; Roebroek AJ
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1258-64. PubMed ID: 19667105
[TBL] [Abstract][Full Text] [Related]
17. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
Sanz-Garcia C; Sánchez Á; Contreras-Jurado C; Cales C; Barranquero C; Muñoz M; Merino R; Escudero P; Sanz MJ; Osada J; Aranda A; Alemany S
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):237-246. PubMed ID: 27856455
[TBL] [Abstract][Full Text] [Related]
18. ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium.
Gaudreault N; Kumar N; Posada JM; Stephens KB; Reyes de Mochel NS; Eberlé D; Olivas VR; Kim RY; Harms MJ; Johnson S; Messina LM; Rapp JH; Raffai RL
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):264-72. PubMed ID: 22053073
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.
Wan W; Lim JK; Lionakis MS; Rivollier A; McDermott DH; Kelsall BL; Farber JM; Murphy PM
Circ Res; 2011 Aug; 109(4):374-81. PubMed ID: 21680896
[TBL] [Abstract][Full Text] [Related]
20. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
